Cargando…

Inhibition of peripheral chemoreceptors improves ventilatory efficiency during exercise in heart failure with preserved ejection fraction − a role of tonic activity and acute reflex response

Peripheral chemoreceptors (PChRs) play a significant role in maintaining adequate oxygenation in the bloodstream. PChRs functionality comprises two components: tonic activity (PChT) which regulates ventilation during normoxia and acute reflex response (peripheral chemosensitivity, PChS), which incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulej-Lyko, Katarzyna, Niewinski, Piotr, Tubek, Stanislaw, Krawczyk, Magdalena, Kosmala, Wojciech, Ponikowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470150/ https://www.ncbi.nlm.nih.gov/pubmed/36111161 http://dx.doi.org/10.3389/fphys.2022.911636

Ejemplares similares

Contribution of Peripheral Chemoreceptors to Exercise Intolerance in Heart Failure
por: Kulej-Lyko, Katarzyna, et al.
Publicado: (2022)

Acute hyperoxia reveals tonic influence of peripheral chemoreceptors on systemic vascular resistance in heart failure patients
por: Tubek, Stanislaw, et al.
Publicado: (2021)

Induction of Day-Time Periodic Breathing is Associated With Augmented Reflex Response From Peripheral Chemoreceptors in Male Patients With Systolic Heart Failure
por: Niewinski, Piotr, et al.
Publicado: (2022)

The Role of Pharmacological Treatment in the Chemoreflex Modulation
por: Langner-Hetmańczuk, Anna, et al.
Publicado: (2022)

Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction
por: Gozdzik, Anna, et al.
Publicado: (2021)

Age-related reflex responses from peripheral and central chemoreceptors in healthy men
por: Paleczny, Bartłomiej, et al.
Publicado: (2014)

The effects of P2Y(12) adenosine receptors’ inhibitors on central and peripheral chemoreflexes
por: Tubek, Stanislaw, et al.
Publicado: (2023)

Heart Failure With Preserved Ejection Fraction vs. Reduced Ejection Fraction　― Mechanisms of Ventilatory Inefficiency During Exercise in Heart Failure ―
por: Tsujinaga, Shingo, et al.
Publicado: (2020)

Early Hemodynamic Changes following Surgical Ablation of the Right Greater Splanchnic Nerve for the Treatment of Heart Failure with Preserved Ejection Fraction
por: Gajewski, Piotr, et al.
Publicado: (2022)

Comparison of haemodynamic response to muscle reflex in heart failure with reduced vs. preserved ejection fraction
por: Moriwaki, Keishi, et al.
Publicado: (2021)

Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM‐HFpEF)
por: Linde, Cecilia, et al.
Publicado: (2022)

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction
por: Butler, Javed, et al.
Publicado: (2022)

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
por: Butler, Javed, et al.
Publicado: (2021)

Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study
por: Franczuk, Paweł, et al.
Publicado: (2023)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2014)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction
por: Kaye, David M., et al.
Publicado: (2018)

The reflex mechanism underlying the neuromuscular effects of whole-body vibration: Is it the tonic vibration reflex?
por: Corum, Mustafa, et al.
Publicado: (2022)

Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial
por: Butler, Javed, et al.
Publicado: (2023)

Pelvic Symmetry Is Influenced by Asymmetrical Tonic Neck Reflex during Young Children’s Gait
por: Gieysztor, Ewa, et al.
Publicado: (2020)

Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
por: Tubek, Stanisław, et al.
Publicado: (2021)

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
por: Pieske, Burkert, et al.
Publicado: (2017)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

High-frequency whole-body vibration activates tonic vibration reflex
por: Kalaoğlu, Eser, et al.
Publicado: (2023)

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
por: Anker, Stefan D., et al.
Publicado: (2022)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017)

Strategies for management of heart failure with preserved ejection fraction
por: Winchester, David E.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b1ajjq3fdvfpu8t55ghvmqdrsv